View Stalevo overdosage for action to be taken in the event of an overdose.
Administration
May be taken with or without food.
Contraindications
Concomitant use of MAOIs (discontinue use at least 2 wk prior to initiating therapy). Severe hepatic impairment. Narrow-angle glaucoma. Pheochromocytoma. History of NMS &/or non-traumatic rhabdomyolysis.
Not for drug-induced extrapyramidal reactions. Severe CV or pulmonary disease, bronchial asthma, renal, hepatic or endocrine disease, or history of PUD or convulsions. History of MI w/ residual atrial nodal or ventricular arrhythmias. Monitor patients for development of mental changes, depression w/ suicidal tendencies & serious anti-social behaviour. Past or current psychosis. Chronic wide-angle glaucoma. May induce orthostatic hypotension. May affect ability to drive or operate machinery. Abrupt dose reductions or w/drawal of levodopa in patients who are also receiving neuroleptics. Periodic evaluation of hepatic, haematopoietic, CV & renal function on extended therapy. Pregnancy & lactation.
N04BA03 - levodopa, decarboxylase inhibitor and COMT inhibitor ; Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.
Sign Out
